ISPOR - PCN289 - HOW ACCELARATED IS PATIENTS’ ACCESS TO NEW ONCOLOGY PRODUCTS IN THE NEW ERA OF CANCER DRUG’S FUND IN ENGLAND?

Full Text

PCN289 - HOW ACCELARATED IS PATIENTS’ ACCESS TO NEW ONCOLOGY PRODUCTS IN THE NEW ERA OF CANCER DRUG’S FUND IN ENGLAND?

Abstract

Authors

B.E. Bates E. Tsoumani

Back to Volume 21, Supplemental S3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now